331 related articles for article (PubMed ID: 12627504)
1. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
Yasui H; Adachi M; Imai K
Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
[TBL] [Abstract][Full Text] [Related]
2. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
[TBL] [Abstract][Full Text] [Related]
3. Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.
Yasui H; Adachi M; Imai K
Ann N Y Acad Sci; 2003 Dec; 1010():273-7. PubMed ID: 15033733
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
Cancer; 2002 Nov; 95(9):1827-33. PubMed ID: 12404274
[TBL] [Abstract][Full Text] [Related]
6. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells.
Sumitomo M; Tachibana M; Nakashima J; Murai M; Miyajima A; Kimura F; Hayakawa M; Nakamura H
J Urol; 1999 Feb; 161(2):674-9. PubMed ID: 9915481
[TBL] [Abstract][Full Text] [Related]
7. Caspase-8-mediated apoptosis in human RPE cells.
Yang P; Peairs JJ; Tano R; Zhang N; Tyrell J; Jaffe GJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3341-9. PubMed ID: 17591907
[TBL] [Abstract][Full Text] [Related]
8. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
[TBL] [Abstract][Full Text] [Related]
9. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
10. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
[TBL] [Abstract][Full Text] [Related]
12. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
[TBL] [Abstract][Full Text] [Related]
13. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.
Zhang S; Lin ZN; Yang CF; Shi X; Ong CN; Shen HM
Carcinogenesis; 2004 Nov; 25(11):2191-9. PubMed ID: 15256485
[TBL] [Abstract][Full Text] [Related]
14. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
16. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma.
Sanlioglu AD; Aydin C; Bozcuk H; Terzioglu E; Sanlioglu S
Lung Cancer; 2004 May; 44(2):199-211. PubMed ID: 15084385
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
19. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.
Nyormoi O; Mills L; Bar-Eli M
Cell Death Differ; 2003 May; 10(5):558-69. PubMed ID: 12728254
[TBL] [Abstract][Full Text] [Related]
20. TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells.
Kimura M; Haisa M; Uetsuka H; Takaoka M; Ohkawa T; Kawashima R; Yamatsuji T; Gunduz M; Kaneda Y; Tanaka N; Naomoto Y
Cell Death Differ; 2003 Jun; 10(6):718-28. PubMed ID: 12761580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
